Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. (SUPN) — Form 425: SEC filing
About this filing
Supernus Pharmaceuticals, Inc. (SUPN) filed Form 425 (sec filing) with the SEC on Oct 6, 2026.
Key facts
- Document
- 425
More SUPN filings
- 10-Q
Filed Oct 29, 2026
- 8-K
Filed Oct 29, 2026
- 8-K
Filed Oct 26, 2026
- 8-K
Filed Oct 21, 2026
- 8-K
Filed Oct 19, 2026
- 8-K
Filed Oct 15, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.